Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods01:21

Dose Size and Dosing Frequency: Determination Methods

370
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
370
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

359
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
359
Volume of Distribution01:20

Volume of Distribution

1.4K
The apparent volume of distribution (Vd) is a crucial pharmacokinetic parameter representing the hypothetical body fluid volume into which a drug disperses. It is calculated based on the total amount of drug in the body (estimated from the administered dose and bioavailability) divided by the plasma drug concentration. The total amount of drug in the body does not directly refer to the dose given but is derived by accounting for absorption, distribution, metabolism, and excretion processes.
1.4K
Compartment Models: Two-Compartment Model01:20

Compartment Models: Two-Compartment Model

7.3K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.3K
Drug Distribution: Volume of Distribution01:25

Drug Distribution: Volume of Distribution

7.7K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
7.7K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses01:25

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

281
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
281

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibiting NCX delays the early onset of Ca<sup>2+</sup> alternans in myocytes from spontaneously hypertensive rats (SHR).

Journal of molecular and cellular cardiology·2025
Same author

Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.

HIV medicine·2024
Same author

Evaluating the usefulness of the estimated glomerular filtration rate for determination of imipenem dosage in critically ill patients.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2022
Same author

Investigating the need for therapeutic drug monitoring of imipenem in critically ill patients: Are we getting it right?

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Standardized delivery room management for neonates with a prenatal diagnosis of congenital heart disease: A model for improving interdisciplinary delivery room care.

Journal of neonatal-perinatal medicine·2020
Same author

Antimicrobial susceptibility and serotype distribution of Streptococcus agalactiae rectovaginal colonising isolates from pregnant women at a tertiary hospital in Pretoria, South Africa: An observational descriptive study.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2020

Related Experiment Video

Updated: Feb 20, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.6K

Analysis of dose heterogeneity using a subvolume-DVH.

M Said1,2, P Nilsson1,2, C Ceberg1

  • 1Medical Radiation Physics, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.

Physics in Medicine and Biology
|October 20, 2017
PubMed
Summary

New methods, the large cold spot metric (LCS) and subvolume-DVH (sDVH), overcome spatial limitations in radiation therapy dose distributions. These approaches provide better insights into dose heterogeneity than standard dose-volume histograms (DVHs).

More Related Videos

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
07:31

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

12.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.2K

Related Experiment Videos

Last Updated: Feb 20, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification ADCI and Dose Estimation

Published on: September 4, 2017

16.6K
Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator
07:31

Characterization of Recombination Effects in a Liquid Ionization Chamber Used for the Dosimetry of a Radiosurgical Accelerator

Published on: May 9, 2014

12.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.2K

Area of Science:

  • Medical Physics
  • Radiation Oncology
  • Image Analysis

Background:

  • The dose-volume histogram (DVH) is a standard tool in radiation therapy for summarizing dose distributions.
  • A key limitation of DVHs is the loss of spatial information, hindering the assessment of dose heterogeneity.
  • Understanding spatial dose distribution is crucial for optimizing treatment efficacy and minimizing toxicity.

Purpose of the Study:

  • To introduce novel methods for overcoming the spatial fragmentation inherent in standard DVHs.
  • To present the large cold spot metric (LCS) and subvolume-DVH (sDVH) as tools to evaluate dose heterogeneity.
  • To demonstrate how these methods provide insights beyond traditional DVH analysis.

Main Methods:

  • Utilized the gray-level size zone matrix, a 2D histogram, to analyze connected regions of similar dose intensities.
  • Developed the large cold spot metric (LCS) to quantify large contiguous regions receiving suboptimal doses.
  • Extended the standard DVH to create the subvolume-DVH (sDVH) for qualitative assessment of dose heterogeneity.

Main Results:

  • The LCS metric quantifies both the size and dose deviation of cold spots, offering a quantitative homogeneity index.
  • The sDVH integrates spatial information onto the standard DVH, allowing for simultaneous qualitative evaluation of heterogeneity.
  • Both LCS and sDVH effectively reveal dose heterogeneity not apparent from standard DVHs.

Conclusions:

  • The LCS and sDVH offer valuable complementary information to standard DVHs in radiation therapy.
  • These methods enhance the understanding of spatial dose distributions, aiding in treatment plan evaluation.
  • The sDVH provides an intuitive visualization, while the LCS offers a quantitative measure of dose inhomogeneity.